ATE482725T1 - Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen. - Google Patents

Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.

Info

Publication number
ATE482725T1
ATE482725T1 AT04758676T AT04758676T ATE482725T1 AT E482725 T1 ATE482725 T1 AT E482725T1 AT 04758676 T AT04758676 T AT 04758676T AT 04758676 T AT04758676 T AT 04758676T AT E482725 T1 ATE482725 T1 AT E482725T1
Authority
AT
Austria
Prior art keywords
cell
progressor
organ failure
based treatment
target
Prior art date
Application number
AT04758676T
Other languages
English (en)
Inventor
Christof Westenfelder
Original Assignee
Us Dept Of Veteran S Affaires
Univ Utah Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Dept Of Veteran S Affaires, Univ Utah Res Found filed Critical Us Dept Of Veteran S Affaires
Application granted granted Critical
Publication of ATE482725T1 publication Critical patent/ATE482725T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/195Chemokines, e.g. RANTES
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04758676T 2003-04-01 2004-03-31 Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen. ATE482725T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45955403P 2003-04-01 2003-04-01
US47517803P 2003-06-02 2003-06-02
PCT/US2004/009922 WO2004090112A2 (en) 2003-04-01 2004-03-31 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

Publications (1)

Publication Number Publication Date
ATE482725T1 true ATE482725T1 (de) 2010-10-15

Family

ID=33162210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04758676T ATE482725T1 (de) 2003-04-01 2004-03-31 Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.

Country Status (7)

Country Link
US (2) US8603462B2 (de)
EP (3) EP2335738A1 (de)
AT (1) ATE482725T1 (de)
AU (2) AU2004227342B2 (de)
CA (3) CA2809195C (de)
DE (1) DE602004029337D1 (de)
WO (1) WO2004090112A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004029337D1 (de) 2003-04-01 2010-11-11 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
US20080241112A1 (en) * 2005-05-10 2008-10-02 Christof Westenfelder Therapy of Kidney Diseases and Multiorgan Failure with Mesenchymal Stem Cells and Mesenchymal Stem Cell Conditioned Media
CA2693382C (en) 2006-09-19 2013-09-17 Insugen, Llc Fused stem cells useful for the treatment of diabetes and methods thereof
WO2008060788A2 (en) 2006-10-11 2008-05-22 The General Hospital Corporation Compositions, methods, and devices for treating liver disease
US20080125490A1 (en) * 2006-11-03 2008-05-29 My Svensson Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids
WO2008109674A2 (en) 2007-03-05 2008-09-12 Caridianbct, Inc. Cell expansion system and methods of use
WO2009065093A2 (en) * 2007-11-17 2009-05-22 University Of Medicine And Dentistry Of New Jersey Use of stem cells for wound healing
US20120156134A1 (en) 2007-12-20 2012-06-21 Shayne Squires Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
US20090291061A1 (en) * 2008-05-21 2009-11-26 Riordan Neil H Stem cell therapy for blood vessel degeneration
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
US20100111908A1 (en) * 2008-11-03 2010-05-06 Fangming Lin Induction of Renal Cells for Treatment of Kidney Disease
JP2013506681A (ja) * 2009-10-02 2013-02-28 バクスター・インターナショナル・インコーポレイテッド 腎損傷の処置における使用のための造血幹細胞
US20120269779A1 (en) * 2009-10-30 2012-10-25 Allocure, Inc. Mesenchymal stromal cell populations and methods of using same
IN2012DN05053A (de) * 2009-12-04 2015-10-09 Stem Cell & Regenerative Medicine Internatioinal Inc
WO2011090605A2 (en) 2009-12-29 2011-07-28 Caridianbct, Inc. Method of loading and distributing cells in a bioreactor of a cell expansion system
CN103180435A (zh) * 2010-08-31 2013-06-26 库克通用生物技术有限责任公司 用于治疗动物疾病的全身的同种异体干细胞疗法
WO2012040408A2 (en) * 2010-09-23 2012-03-29 Children's Medical Center Corporation Engineered vascular adipose tissue
WO2012048298A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US20130287747A1 (en) * 2012-04-30 2013-10-31 Allocure, Inc. Methods of Treating Acute Kidney Injury Using Mesenchymal Stem Cells
EP2885393A1 (de) 2012-08-20 2015-06-24 Terumo BCT, Inc. Verfahren zum laden und verteilen von zellen in einem bioreaktor eines zellexpansionssystems
EP3068867B1 (de) 2013-11-16 2018-04-18 Terumo BCT, Inc. Zellenexpansion in einem bioreaktor
JP2015160820A (ja) * 2014-02-26 2015-09-07 株式会社Clio 慢性腎障害治療のための多能性幹細胞
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
US10077421B2 (en) 2014-04-24 2018-09-18 Terumo Bct, Inc. Measuring flow rate
CN106536056B (zh) 2014-06-13 2021-07-16 儿童医学中心公司 分离线粒体的产品和方法
CN106715676A (zh) 2014-09-26 2017-05-24 泰尔茂比司特公司 按计划供养
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US20170151287A1 (en) 2015-11-30 2017-06-01 Flagship Ventures Management, Inc. Methods and compositions of chondrisomes
EP3402490B1 (de) * 2016-01-15 2022-06-01 The Children's Medical Center Corporation Therapeutische verwendung von mitochondrien und kombinierte mitochondrienmittel
EP3405566B1 (de) 2016-01-21 2023-10-18 ABT Holding Company Stammzellen für heilung von hautgeschwüren
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2018184028A2 (en) 2017-03-31 2018-10-04 Terumo Bct, Inc. Cell expansion
CN108646035B (zh) * 2018-05-18 2021-06-11 北京亦科诺生物科技有限公司 胰岛素样生长因子1的新应用
JP2022517531A (ja) * 2019-01-18 2022-03-09 アブラハム ジェイ アンド フィリス カッツ コード ブラッド ファウンデーション 神経学的疾患のための二重幹細胞治療
US20230020486A1 (en) * 2019-12-19 2023-01-19 University Of Miami Stem Cell Delivery
JP2024511064A (ja) 2021-03-23 2024-03-12 テルモ ビーシーティー、インコーポレーテッド 細胞捕獲及び増殖

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US475178A (en) 1892-05-17 Electrical forge
US459554A (en) 1891-09-15 Fence-wire stretcher
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5733542A (en) 1990-11-16 1998-03-31 Haynesworth; Stephen E. Enhancing bone marrow engraftment using MSCS
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US6010696A (en) 1990-11-16 2000-01-04 Osiris Therapeutics, Inc. Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5591625A (en) 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US6174333B1 (en) 1994-06-06 2001-01-16 Osiris Therapeutics, Inc. Biomatrix for soft tissue regeneration using mesenchymal stem cells
DK0952792T3 (da) 1994-06-06 2003-12-08 Osiris Therapeutics Inc Biomatrix til vævsregeneration
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5643736A (en) 1995-02-06 1997-07-01 Osiris Therapeutics, Inc. Monoclonal antibodies for human osteogenic cell surface antigens
US5908782A (en) 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
PT868505E (pt) 1995-11-16 2005-06-30 Univ Case Western Reserve Inducao condrogenica in vitro de celulas estaminais mesenquimais humanas
US6482231B1 (en) 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
EP2311471A3 (de) 1996-04-19 2013-05-15 Osiris Therapeutics, Inc. Regenerierung und Vermehrung von Knochen unter Verwendung von mesenchymalen Stammzellen
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
EP0941027A4 (de) 1996-11-15 2000-08-09 Osiris Therapeutics Inc MSC-Megakaryozytenvorläuferzusammensetzung und Verfahren zum Isolieren von mit isolierten Megakaryozyten assoziierten MSCS durch die Isolierung von Megakaryozyten
PT1028737E (pt) 1997-07-03 2007-07-11 Osiris Therapeutics Inc Células estaminais mesenquimatosas humanas de sangue periférico
AU8401498A (en) 1997-07-14 1999-02-10 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
WO1999011287A1 (en) 1997-09-04 1999-03-11 Osiris Therapeutics, Inc. Ligands that modulate differentiation of mesenchymal stem cells
US6149906A (en) 1997-09-20 2000-11-21 Osiris Therapeutics, Inc. Antigen presenting cells of the adipocyte lineage
WO1999018207A1 (en) 1997-10-03 1999-04-15 Osiris Therapeutics, Inc. Human hox c10 and polynucleotides encoding
US6429012B1 (en) 1997-10-06 2002-08-06 Viacell, Inc. Cell population containing non-fetal hemangioblasts and method for producing same
AU1203999A (en) 1997-10-31 1999-05-24 Osiris Therapeutics, Inc. Human slit polypeptide and polynucleotides encoding same
AU749675B2 (en) 1998-03-13 2002-07-04 Mesoblast International Sarl Uses for human non-autologous mesenchymal stem cells
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
JP4740452B2 (ja) 1998-03-18 2011-08-03 オシリス セラピューティクス,インコーポレイテッド 移植で免疫応答の予防と処置のための間葉幹細胞を利用する方法、組成物およびその使用法
WO1999061588A1 (en) 1998-05-22 1999-12-02 Osiris Therapeutics, Inc. Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
AU4221399A (en) 1998-05-29 1999-12-13 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
AU4336599A (en) 1998-06-08 1999-12-30 Osiris Therapeutics, Inc. (in vitro) maintenance of hematopoietic stem cells
ATE375799T1 (de) 1998-06-08 2007-11-15 Osiris Therapeutics Inc Regulierung der hämatopoietischen stammzelldifferenzierung durch verwendung von menschlichen mesenchymalen stammzellen
US6372494B1 (en) 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6239157B1 (en) 1999-09-10 2001-05-29 Osiris Therapeutics, Inc. Inhibition of osteoclastogenesis
US6685936B2 (en) 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US20020151496A1 (en) 2000-12-08 2002-10-17 Bringmann Peter W. Novel fibroblast growth factors
WO2003013588A1 (fr) * 2001-08-08 2003-02-20 Kaken Pharmaceutical Co., Ltd. Materiau de regeneration de rein comprenant des cellules et un facteur de croissance cellulaire
AU2003225791A1 (en) * 2002-03-15 2003-09-29 Department Of Veterans Affairs, Rehabilitation R And D Service Methods and compositions for directing cells to target organs
JP2006505380A (ja) 2002-11-05 2006-02-16 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 間葉幹細胞およびその使用方法
EP1583422B1 (de) * 2002-12-05 2016-03-30 Case Western Reserve University Ischämie-therapien auf zellgrundlage
DE602004029337D1 (de) 2003-04-01 2010-11-11 Us Dept Of Veteran S Affaires Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.

Also Published As

Publication number Publication date
CA2784829A1 (en) 2004-10-21
WO2004090112B1 (en) 2005-04-21
US20070178071A1 (en) 2007-08-02
EP1608411B1 (de) 2010-09-29
US8603462B2 (en) 2013-12-10
CA2809195A1 (en) 2004-10-21
EP1608411A2 (de) 2005-12-28
CA2521217A1 (en) 2004-10-21
CA2809195C (en) 2014-05-20
EP2263698A1 (de) 2010-12-22
EP1608411A4 (de) 2007-08-29
US20140086886A1 (en) 2014-03-27
CA2521217C (en) 2013-05-14
WO2004090112A3 (en) 2005-03-10
WO2004090112A2 (en) 2004-10-21
DE602004029337D1 (de) 2010-11-11
AU2004227342A1 (en) 2004-10-21
AU2011200017A1 (en) 2011-01-27
EP2335738A1 (de) 2011-06-22
CA2784829C (en) 2015-10-06
AU2004227342B2 (en) 2011-01-20
AU2011200017B2 (en) 2012-04-19

Similar Documents

Publication Publication Date Title
ATE482725T1 (de) Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen.
WO2006121445A3 (en) Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media
ATE482712T1 (de) Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen
ATE395924T1 (de) Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen
AR047712A1 (es) Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
EP2298862A3 (de) Mesenchymale Stammzellen und deren Verwendungen
ATE408412T1 (de) Verwendung von cannabidiol zur hemmung von gehirntumorzellmigration
ATE358493T1 (de) Menschliche mesenchymale stammzellen aus peripherem blut
DK1885382T3 (da) Fremgangsmåder til anvendelse af adipøst vævs-afledte celler i behandlingen af cardiovaskulære tilstande
PE20070244A1 (es) Biotejido de colageno derivado de placenta para el tratamiento de ulceras en la pierna
WO2006050330A3 (en) Platelets from stem cells
EA200400482A1 (ru) Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
DE60118604D1 (de) Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen
WO2005120549A3 (en) Local delivery of growth factors for stem cell transplantation
ECSP045085A (es) Stent o injerto vascular recubierto con inhibidores de la proteína tirosina quinasa y método de usar el mismo
HK1205531A1 (en) Mesenchymal stem cells and uses therefor
IS2405B (is) Notkun dextransúlfats til að meðhöndla skyndilegtblóðmiðlað bólguviðbragð (IBMIR)
ECSP014131A (es) Un metodo para la reduccion de nitrosaminas especificas del tabaco
NO2019032I1 (no) Treosulfan
RU2007148109A (ru) Способ лечения хронической и острой почечной недостаточности с помощью фетальных стволовых и прогениторных клеток человека
RU2005100172A (ru) Способ косметического лечения дефектов мягких тканей лица
DE60119285D1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
FR2835429B1 (fr) Utilisation d'acide ascorbique pour renforcer la cohesion de la jonction dermo-epidermique
DE60023006D1 (de) Neues verfahren zur herstellung und auswahl von transgenen flachspflanzen und leinsamen
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties